FDA Approved: GLIPIZIDE AND METFORMIN HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Teva's generic combination tablet of glipizide and metformin hydrochloride.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glipizide and Metformin Hydrochloride (glipizide and metformin hydrochloride)

Snippet

SUPPL AP for GLIPIZIDE AND METFORMIN HYDROCHLORIDE (GLIPIZIDE AND METFORMIN HYDROCHLORIDE)